Annexon (ANNX) · tanruprubart
Narrower window · A neutral label from comparing the two stated windows. It says nothing about the program’s results.
Before
Stated timing: 2026
Next Milestone: BLA submission with initial U.S./European data from FORWARD trial anticipated in 2026.
EX-99.1 · filed · SEC filing
After
Stated timing: fourth quarter of 2026
Biologics License Application (BLA) submission with U.S./European data from FORWARD trial expected in fourth quarter of 2026.
EX-99.1 · filed · SEC filing
Data as of . Both sentences are quoted from the SEC filings linked above and matched to them.
Source: ORION, orionbiotechai.com/changes/ANNX-tanruprubart-2026-08-12, data as of Oct 13, 2026
https://www.orionbiotechai.com/changes/ANNX-tanruprubart-2026-08-12
Annexon (ANNX) pipeline and stated timing · Calendar · Companies A–Z